Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 48 views
- Expect Even More Unique Electric Cars Says Ferrari 39 views
- 4CABLE TV INTERNATIONAL, INC. ANNOUNCES SETTLEMENT OF THE MARQUIS TRADING DEBT, OPENING OF THE FIRST OF ITS KIND HIP RESTAURANT AND THE UNDERGOING OF REPAIRS AT THE CIGN FARM 32 views
- Sequoia Capital Raises $2.85 Billion to Fund Indian and Southeast Asian Startups 28 views
- U.S Resumes Talks With Embattled Huawei CFO Meng Wanzhou 24 views